Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Cytomegalovirus Seroposivity in Iranian Multiple Sclerosis: A Randomized Case-Control Study



Ashtari F1 ; Fatehi F2 ; Akbari M1 ; Ghalamkari S3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Isfahan Neuroscience Research Centre, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Tehran University of Medical Sciences, Tehran, Iran
  3. 3. ITM Research Centre, Isfahan University, Isfahan, Iran

Source: Pakistan Journal of Medical Sciences Published:2012

Abstract

Objective: Multiple sclerosis (MS) is an inflammatory demyelinating disease of central nervous system. Environmental factors such as different viruses have proposed to be involved in the pathogenesis of multiple sclerosis (MS). This study was aimed to evaluate Cytomegalovirus (CMV) seropositivity in Iranian patients suffering from MS compared to controls. Methodology: This case control study was conducted in Isfahan. Using ELISA method, IgM and IgG antibodies to Cytomegalovirus (CMV) in MS patients and age and sex matched controls were detected. CMV IgM titer higher than 25 and CMV IgG titer higher than 0.6 were regarded as seropositive according to laboratory Kit. Results: Total 82 MS patients (64 females and 18 males) and 38 controls (29 females and 9 males) were included (P>0.05). The median [IQR] titer of CMV IgM in MS group was 3.25[2.97- 5.1] versus 3.5[2.5-5.7] in control group (p=0.66); likewise, the median [IQR] titer of CMV IgG in MS patients was 15.15 [8.1-22.5] versus 7.75[5.3-22] in control group (p=0.011). According clinical course median of IgG was 14.94[7.3-24] in RRMS and 20.0[9.8-22] in SPMS and median of IgM was 4.0[2.9-6.5] and 3.0[2.7-4.0] respectively. Conclusion: Seropositivity of CMV was higher in MS patients than controls, therefore, it may have a possible role in MS pathogenesis, but further studies are needed to evaluate this result.
Other Related Docs
17. Covid-19 Among Patients With Multiple Sclerosis a Systematic Review, Neurology: Neuroimmunology and NeuroInflammation (2021)
21. Mizaj Assessment in Multiple Sclerosis (Ms) Patients Based on Persian Medicine, Journal of Complementary and Integrative Medicine (2022)
22. Lateonset Multiple Sclerosis in Isfahan, Iran, Archives of Iranian Medicine (2012)
25. Torque Teno Mini Virus Infection and Multiple Sclerosis, International Journal of Neuroscience (2011)
26. Serum Level of Interleukin 36 in Patients With Multiple Sclerosis, Journal of Immunoassay and Immunochemistry (2018)
27. Mannose-Binding Lectin Mediated Complement Pathway in Autoimmune Neurological Disorders, Iranian Journal of Allergy, Asthma and Immunology (2016)
28. Multiple Sclerosis in Isfahan, Iran, International Review of Neurobiology (2007)
40. Clinical and Epidemiological Aspects of Multiple Sclerosis in Children, Iranian Journal of Child Neurology (2017)
42. Serum Homocysteine Level in Patients With Multiple Sclerosis, Journal of Research in Medical Sciences (2005)